PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2020-06-24

Date Title Company
24-Jun-2020 GW Pharmaceuticals announces that EPIDYOLEX® (cannabidiol) has been reclassified by the UK Home Office as a Schedule 5 drug GW Pharmaceuticals plc
24-Jun-2020 Roivant Sciences continues its partnership with BaseLaunch for Phase II Roivant Sciences
24-Jun-2020 Zelluna Immunotherapy announces a collaboration with Lion TCR to develop allogeneic “off-the-shelf” TCR based Natural Killer (TCR-NK) cell therapies for the treatment of virally induced cancers Zelluna Immunotherapy
24-Jun-2020 Sanofi’s virtual R&D Day event to highlight capabilities, platforms, and expertise in disease pathways to deliver potentially transformative treatments to patients Sanofi
24-Jun-2020 Sanofi and Translate Bio expand collaboration to develop mRNA vaccines across all infectious disease areas Sanofi Pasteur
24-Jun-2020 UK’s MHRA renews EAMS Scientific Opinion for Santhera’s Idebenone in Duchenne Muscular Dystrophy Santhera Pharmaceuticals
24-Jun-2020 Evelo Biosciences Announces EDP1815 to Advance into Phase 2/3 TACTIC-E COVID-19 Trial Evelo Biosciences
24-Jun-2020 2018-19 Figures Show Almac Group’s Turnover Increased by £85M to £634M 7% growth in global workforce to over 5,100 during same period Almac Group
24-Jun-2020 Transgene presents promising new data from its next-generation immunotherapy platforms at AACR 2020 Transgene
24-Jun-2020 Medigene AG: Medigene's PD1-41BB switch receptor enhances TCR-T cell activity towards solid tumors Medigene AG
24-Jun-2020 PureTech Presents New Data Reinforcing Galectin-9 as a Compelling Therapeutic Target and Biomarker for a Range of Cancers at the American Association for Cancer Research Annual Meeting PureTech Health plc
24-Jun-2020 ILC Therapeutics announces partnership with University of St Andrews to combat COVID-19 ILC Therapeutics
24-Jun-2020 Orgenesis and Leidos Collaborate on Potential Treatment for COVID-19 Orgenesis Inc
24-Jun-2020 Rexgenero acquires the key technology and program assets of aratinga.bio SAS Group Rexgenero
24-Jun-2020 Jubilant Therapeutics Presents Preclinical Data at the American Association for Cancer Research, Reveals Unique Dual-Action Anti-Cancer Mechanism Underscoring First-in-Class Pipeline Asset in Hematological Tumors Jubilant Therapeutics Inc
24-Jun-2020 Autolus Therapeutics presents new preclinical data during the Virtual 2020 AACR Annual Meeting Autolus Therapeutics
24-Jun-2020 Intranasal immunization with Intravacc’s experimental whooping cough vaccine confers broad protection Intravacc
24-Jun-2020 Sanofi’s investigational enzyme replacement therapy shows meaningful results in clinical manifestations of late-onset Pompe disease1 Sanofi
24-Jun-2020 EPIDAREX CAPITAL CLOSES NEW £102 MILLION UK VENTURE FUND TO BUILD SUCCESSFUL LIFE SCIENCE COMPANIES Epidarex Capital
24-Jun-2020 Evelo Biosciences Announces EDP1815 to Advance into Phase 2/3 TACTIC-E COVID-19 Trial Evelo Biosciences